Harrow (HROW) said Monday it partnered with Cencora (COR) to launch "Harrow Cares," a patient support program for its IHEEZO and TRIESENCE treatments for retina care.
Financial terms were not provided.
The eyecare pharmaceutical company said the program includes enrollment support, real-time benefit verification, copay assistance, and product replacement services.